These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34712779)

  • 1. Rejection-associated Phenotype of De Novo Thrombotic Microangiopathy Represents a Risk for Premature Graft Loss.
    Petr V; Hruba P; Kollar M; Krejci K; Safranek R; Stepankova S; Dedochova J; Machova J; Zieg J; Slatinska J; Pokorna E; Viklicky O
    Transplant Direct; 2021 Nov; 7(11):e779. PubMed ID: 34712779
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Petr V; Csuka D; Hruba P; Szilágyi Á; Kollar M; Slavcev A; Prohászka Z; Viklicky O
    Front Immunol; 2022; 13():985766. PubMed ID: 36189289
    [No Abstract]   [Full Text] [Related]  

  • 3. The inferior impact of antibody-mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy.
    Wu K; Budde K; Schmidt D; Neumayer HH; Lehner L; Bamoulid J; Rudolph B
    Clin Transplant; 2016 Feb; 30(2):105-17. PubMed ID: 26448478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unveiling the Incidence and Graft Survival Rate in Kidney Transplant Recipients With
    Hsiung CY; Chen HY; Wang SH; Huang CY
    Transpl Int; 2024; 37():12168. PubMed ID: 38323071
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO-incompatible kidney transplantation and the associated risk factors.
    Tasaki M; Saito K; Nakagawa Y; Imai N; Ito Y; Yoshida Y; Ikeda M; Ishikawa S; Narita I; Takahashi K; Tomita Y
    Int J Urol; 2019 Dec; 26(12):1128-1137. PubMed ID: 31587389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo thrombotic microangiopathy after kidney transplantation.
    Garg N; Rennke HG; Pavlakis M; Zandi-Nejad K
    Transplant Rev (Orlando); 2018 Jan; 32(1):58-68. PubMed ID: 29157988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical profile and outcomes of
    Saikumar Doradla LP; Lal H; Kaul A; Bhaduaria D; Jain M; Prasad N; Thammishetti V; Gupta A; Patel M; Sharma RK
    Saudi J Kidney Dis Transpl; 2020; 31(1):160-168. PubMed ID: 32129209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo thrombotic microangiopathy in two kidney transplant recipients from the same deceased donor: A case series.
    Roberts D; Siegman I; Andeen N; Woodland D; Deloughery T; Rueda J; Olyaei A; Rehman S; Norman D; Lockridge J
    Clin Transplant; 2020 Jul; 34(7):e13885. PubMed ID: 32314417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
    Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
    Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.
    Cuevas E; Arreola-Guerra JM; Hernández-Méndez EA; Salcedo I; Castelán N; Uribe-Uribe NO; Vilatobá M; Contreras-Saldívar AG; Sánchez-Cedillo AI; Ramírez JB; de Rungs D; Granados J; Morales-Buenrostro LE; Alberú J
    Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic microangiopathy and peritubular capillary C4d expression in renal allograft biopsies.
    Meehan SM; Kremer J; Ali FN; Curley J; Marino S; Chang A; Kadambi PV
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):395-403. PubMed ID: 20966124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR).
    Hariharan S; Adams MB; Brennan DC; Davis CL; First MR; Johnson CP; Ouseph R; Peddi VR; Pelz CJ; Roza AM; Vincenti F; George V
    Transplantation; 1999 Sep; 68(5):635-41. PubMed ID: 10507481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the role of the complement system, endothelial injury, and microRNAs in thrombotic microangiopathy after kidney transplantation.
    Aleš Rigler A; Večerić-Haler Ž; Arnol M; Perše M; Boštjančič E; Pleško J; Simčič S; Kojc N
    J Int Med Res; 2020 Dec; 48(12):300060520980530. PubMed ID: 33372813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy.
    Schwimmer J; Nadasdy TA; Spitalnik PF; Kaplan KL; Zand MS
    Am J Kidney Dis; 2003 Feb; 41(2):471-9. PubMed ID: 12552512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation.
    Postalcioglu M; Kim HT; Obut F; Yilmam OA; Yang J; Byun BC; Kupiec-Weglinski S; Soiffer R; Ritz J; Antin JH; Alyea E; Koreth J; Cutler C; Armand P; Paik JM; Leaf DE; Ho VT; Abdi R
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2344-2353. PubMed ID: 29758394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo thrombotic microangiopathy. An underrated complication of renal transplantation.
    Ponticelli C
    Clin Nephrol; 2007 Jun; 67(6):335-40. PubMed ID: 17598367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of de novo donor-specific anti-HLA antibodies in kidney graft failure: A case-control study.
    Castro A; Malheiro J; Tafulo S; Dias L; Martins LS; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
    HLA; 2017 Nov; 90(5):267-275. PubMed ID: 28776960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss - a retrospective study.
    Cioni M; Nocera A; Tagliamacco A; Basso S; Innocente A; Fontana I; Magnasco A; Trivelli A; Klersy C; Gurrado A; Ramondetta M; Boghen S; Catenacci L; Verrina E; Garibotto G; Ghiggeri GM; Cardillo M; Ginevri F; Comoli P
    Transpl Int; 2019 Jan; 32(1):38-48. PubMed ID: 30076765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine-associated thrombotic microangiopathy in renal allografts.
    Zarifian A; Meleg-Smith S; O'donovan R; Tesi RJ; Batuman V
    Kidney Int; 1999 Jun; 55(6):2457-66. PubMed ID: 10354295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic microangiopathy after renal transplantation: Current insights in
    Abbas F; El Kossi M; Kim JJ; Sharma A; Halawa A
    World J Transplant; 2018 Sep; 8(5):122-141. PubMed ID: 30211021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.